cbdMD, Inc. Common Stock (YCBD) is a publicly traded Healthcare sector company. As of May 21, 2026, YCBD trades at $0.74 with a market cap of $8.08M and a P/E ratio of 5.17. YCBD moved -2.64% today. Year to date, YCBD is -33.21%; over the trailing twelve months it is -20.00%. Its 52-week range spans $0.47 to $6.54. Analyst consensus is buy with an average price target of $2.00. Rallies surfaces YCBD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes YCBD SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $0.74 |
| Market Cap | $8.08M |
| P/E Ratio | 5.17 |
| EPS | $0.14 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.54 |
| 52-Week Low | $0.47 |
| Volume | 1.12K |
| Avg Volume | 0 |
| Revenue (TTM) | $19.98M |
| Net Income | $-2.66M |
| Gross Margin | 59.38% |
1 analysts cover YCBD: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.00.